ezetimibe has been researched along with Spastic Paraplegia, Hereditary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carecchio, M; Del Puppo, M; Di Bella, D; Dotti, MT; Magistrelli, L; Mignarri, A; Monti, L | 1 |
| Del Puppo, M; Dotti, MT; Federico, A; Ginanneschi, F; Magni, A; Malandrini, A; Mignarri, A; Monti, L; Santorelli, FM; Tessa, A | 1 |
2 other study(ies) available for ezetimibe and Spastic Paraplegia, Hereditary
| Article | Year |
|---|---|
SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment.
Topics: Adult; Anticholesteremic Agents; Brain; Cytochrome P450 Family 7; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxycholesterols; Middle Aged; Phenotype; Siblings; Simvastatin; Spastic Paraplegia, Hereditary; Steroid Hydroxylases; Treatment Outcome | 2017 |
Treatment of SPG5 with cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Ezetimibe; Follow-Up Studies; Humans; Hydroxycholesterols; Siblings; Simvastatin; Spastic Paraplegia, Hereditary | 2015 |